Home > > Middle East & Africa And Global Chemiluminescence Immunoassay Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Chemiluminescence Immunoassay market was valued at $736.6 Million in 2023, and is projected to reach $1,214.2 Million by 2030 growing at a CAGR of 7.46% from 2024 to 2030. Consumables segment is expected to be the highest contributor to this market, with $512.6 Million in 2023, and is anticipated to reach $824.6 by 2030, registering a CAGR of 7.08%. Instruments segment is anticipated to reach $347.4 Million by 2030 with the highest CAGR of 8.83%. Consumables and Instruments segments collectively expected to account for about 95.8% share of the Middle East & Africa Chemiluminescence Immunoassay market in 2023, with the former constituting around 69.6% share. Instruments and Consumables segments are expected to witness significant growth rates at a CAGR of 8.83% and 7.08% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 95.8% in the overall Middle East & Africa Chemiluminescence Immunoassay market in 2023, and is anticipated to reach 96.5% by 2030. Product Instruments Consumables Software & Services Application Therapeutic Drug Monitoring Oncology Cardiology Endocrinology Infectious Disease Autoimmune Disease Other Applications End-use Hospitals Clinical Laboratories Pharmaceutical & Biotechnology Companies Other End-Uses BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA